Introduction {#Sec1}
============

*Rheum palmatum* is a traditional Chinese medicine widely used in treatment of gasteroenteritic and liver diseases (Li et al. [@CR14]). *R. palmatum* and related components are associated with a great variety of anti-cancer and anti-virus properties (Li et al. [@CR14]; Huang et al. [@CR7]; Lin et al. [@CR16]; Semple et al. [@CR23]; Sydiskis et al. [@CR25]; Wohlfarth and Efferth [@CR28]). Many natural compounds have been identified from *R. palmatum*, including chrysophanol, rhein, emodin, aloe-emodin, sennoside A and physcion (Li et al. [@CR14]). Aloe-emodin displays potent anti-virus activities and anti-cancer properties (Lin et al. [@CR15]; Mijatovic et al. [@CR18]; Kuo et al. [@CR11]). Aloe-emodin exhibits multiple anti-viral effects (Huang et al. [@CR7]; Sydiskis et al. [@CR25]) against herpes simplex, influenza (Sydiskis et al. [@CR25]), human cytomegalovirus (Barnard et al. [@CR2]), and polio viruses (Semple et al. [@CR23]). Both emodin and chrysophanol show antiviral activity against hepatitis B (Shuangsuo et al. [@CR24]), polio (Semple et al. [@CR23]), human immunodeficiency and hepatitis C (Kubin et al. [@CR10]).

Japanese encephalitis virus (JEV), a mosquito-borne virus, belongs to the genus *Flavivirus* of the family *Flaviviridae*. JEV causes severe central nerve system diseases such as poliomyelitis-like acute flaccid paralysis, aseptic meningitis and encephalitis, the latter still a leading cause of high morbidity and mortality (Unni et al. [@CR26]). JEV vaccines are currently accessible and effective, but zoonotic and occasional infections still occur in Southeast Asia and the Western Pacific region (Chung et al. [@CR5]). Among an estimated 35,000--50,000 annual cases, 30--50 % of JEV patients develop permanent neuropsychiatric sequelae and 20--30 % result in death (Kaur and Vrati [@CR9]). Extensive studies aimed at developing new antiviral therapeutic strategies may also be needed.

In this study, methanol and water extracts of *R. palmatum* and its related natural compounds were rated for inhibiting JEV replication in vitro. We demonstrated methanol and water extracts of *R. palmatum* reducing JEV plaques and virus yields in vitro. Derived components chrysophanol and aloe-emodin were less cytotoxic and exhibited IC~50~ values less than 20 μg/ml against JEV. We proved that anti-JEV ability of those extracts correlates with potent virucidal effects on JEV infectivity and activates interferon-γ-activated site (GAS)-driven promoter. We first reported antiviral activity of chrysophanol and aloe-emodin against JEV via virucidal efficacy and GAS promoter activation.

Materials and methods {#Sec2}
=====================

Viruses and cells {#Sec3}
-----------------

JEV strain T1P1 kindly provided by Prof. Wei-June Chen at Chang Gung University (Taoyuan, Taiwan) was used as previously described (Hsiao et al. [@CR6]). Vero cells (African green monkey kidney cells, ATCC No. CCL-81) for JEV amplification were maintained in Dulbecco's modified Eagle's medium (DMEM), BHK-21 cells (baby hamster kidney cells, ATCC No. CCL-10) used to determine JEV plaques, with virus yields grown in minimum essential medium (MEM) supplemented with 10 % fetal bovine serum (FBS).

Chemicals and *R. palmatum* extracts {#Sec4}
------------------------------------

Crude *R. palmatum* extract powder was obtained from Sun Ten Pharmaceutical Co., Ltd. For each tested extract, 1 g of powder was dissolved in 40 ml methanol or distilled water and gently shaken overnight at room temperature. Solution samples were filtered with Whatman No. 1 filter paper, lyophilized in an IWAKI FDR-50P freeze dryer, then sterilized by a 0.44 μm syringe filter and stored at −80 °C until used (100 % stock solution). Also, filtered extract was injected directly into the HPLC instrument with C-18 reverse phase column. Separation was conducted with gradient elution using acetonitrile and 0.1 % phosphoric acid at a flow rate of 1 ml/min, eluent detected at 250 nm. Chrysophanol, rhein, emodin, aloe-emodin, and physcion were purchased from Sigma Chemical Co. of St. Louis, serving as external standards for comparing chromatographic peaks of methanol and water extracts with the retention time of these marker compounds.

Cell viability assay {#Sec5}
--------------------

For cell viability assay, BHK-21 cells were cultured overnight on 96-well plates. Medium containing various concentrations of *R. palmatum* extract, chrysophanol, rhein, emodin, aloe-emodin, or physcion was added and incubated for another 72 h, followed by MTT assay. Survival rate of cells was calculated as ratio of optical density at 570--630 nm (OD~570--630~) of treated cells to OD~570--630~ of untreated cells. Cytotoxic rate (%) = \[(*A* ~control~ − *A* ~experiment~)/*A* ~control~\] × 100 %. Cytotoxic concentration giving 50 % (CC~50~) was determined as using a computer program (provided by John Spouge, NCBI, NIH).

Plaque reduction assay {#Sec6}
----------------------

To determine viral plaque reduction effect, medium containing various concentrations of *R. palmatum* extract, chrysophanol, or aloe-emodin was added along with JEV at 100 pfu, added into the well of BHK-21 cell monolayer at 37 °C for 1 h and then overlaid with MEM medium containing 1.1 % methylcellulose. Viral plaques were stained with naphthol blue-black dye after three days of incubation. The data represent mean ± SD of three independent experiments. Inhibitory concentration showing 50 % JEV plaque reduction (IC~50~) was determined using a computer program (provided by John Spouge, National Institutes of Health).

Virucidal activity assays {#Sec7}
-------------------------

Virucidal assay was modified as a prior study (Cheng et al. [@CR4]). JEV (10^5^ pfu) was mixed with medium containing *R. palmatum* extract, chrysophanol, or aloe-emodin (0, 1, 10, 100 μg/ml), then incubated for 60 min at room temperature. A 1,000-fold dilution of each extract/virus or compound/virus mixture was added onto BHK-21 cell monolayer in 6-well plates for plaque assays. Residual infectivity and inhibitory concentration showing 50 % JEV plaque reduction (IC~50~) were performed as described in the plaque assay.

Quantitative assay of virus yields using real-time RT-PCR assay {#Sec8}
---------------------------------------------------------------

To determine inhibitory effect on virus yields, *R. palmatum* extract, chrysophanol, or aloe-emodin was mixed with JEV at a MOI of 1, each mixture forthwith added into BHK-21 cells for 72 h. Cultured supernatants were harvested for viral genome extraction, using QIAamp Viral RNA Mini Kit (Qiagen). Real-time RT-PCR is performed with specific primers, SYBR green PCR Master Mix and SYBR green I dsDNA binding dye. Oligonucleotides for JEV E protein were JEV D3-F 5′-GGGAGTGATGGCCCCTGCAAAATT-3′ and JEV D3-R 5′-TCCAATGGAGCCAAAGTCCCAGGC-3′ as described previously (Huang et al. [@CR8]). PCR product level was monitored with an ABI PRISM 7000 sequence detection system (Applied Biosystems).

GAS-driven promoter assay {#Sec9}
-------------------------

BHK-21 cells were co-trasfected with a cis-reporter plasmid pGAS-Luc (Agilent Technologies, Catalog NO. 219091) and an internal control reporter pRluc-C1 (BioSignal Packard) in 6-well plates, using GenePorter reagent. Transfected cells were seeded into 24-well plates with DMEM containing 10 % FBS and treated with chrysophanol, or aloe-emodin at a concentration of 10 μg/ml. After 4-h incubation, enzyme activity of experimental firefly luciferase and control Renilla luciferase in cells was measured with dual Luciferase Reporter Assay System (Promega) and Luminometer TROPIX TR-717 (Applied Biosystems). Relative firefly luciferase activity of GAS-driven reporter was normalized by Renilla luciferase, then compared to untreated cells. Assays were performed in triplicate, the results expressed as mean ± SD.

Statistical analysis {#Sec10}
--------------------

ANOVA analysis using SPSS program (version 10.1, SPSS Inc., IL, USA) or Student *t* test analyzed all data. *P* \< 0.05 was considered statistically significant.

Results {#Sec11}
=======

HPLC and cytotoxic analyses of *R. palmatum* extracts {#Sec12}
-----------------------------------------------------

To determine fingerprints of *R. palmatum* extracts, methanol and water extracts were analyzed using HPLC (Fig. [1](#Fig1){ref-type="fig"}). Chrysophanol, rhein, emodin, aloe-emodin, and physcion served as external standards, while retention time was 9 min for aloe-emodin, 10 min for rhein, 18 min for emodin, 30 min for chrysophanol, and 40 min for physcion (Fig. [1](#Fig1){ref-type="fig"}a).Comparison of chromatographic peaks of extracts with retention time of these marker compounds showed methanol extract containing higher amounts of the five marker components than water extract (Figs [1](#Fig1){ref-type="fig"}b, c). *R. palmatum* extracts and these five marker compounds were further evaluated their cytotoxicity to BHK-21 cells. In vitro cytotoxicity assay indicated CC~50~ values of both *R. palmatum* extract and related marker compounds varying from 3.47 μg/ml (rhein) to 54.80 μg/ml (*R. palmatum* water extract) 72 h post treatment (Table [1](#Tab1){ref-type="table"}). Rhein and emodin showed high toxicity to BHK-21 cells (CC~50~ \< 10 μg/ml); chrysophanol and aloe-emodin were less toxic.Fig. 1HPLC chromatogram of a mixture solution of marker components (**a**), methanol (**b**), and water (**c**) extracts of *R. palmatum*. HPLC was performed with a C-18 reverse phase column with gradient elution using acetonitrile and 0.1 % phosphoric acid at a flow rate of 1 ml/min; eluent detected at 250 nm Table 1Cytotoxic and anti-JEV activities of *R. palmatum* extracts and major components*R. palmatum*CC50 (μg/ml)IC50 (μg/ml)Virucidal IC50 (μg/ml)Methanol extract31.07 ± 3.9115.04 ± 5.157.58 ± 0.16Water extract54.80 ± 1.4351.41 ± 4.9517.36 ± 2.92Chrysophanol18.18 ± 5.5315.82 ± 2.620.75 ± 0.25Rhein3.47 ± 2.88Emodin5.49 ± 1.82Aloe-emodin20.18 ± 1.0117.39 ± 0.580.46 ± 0.15Physcion20.69 ± 4.66

JEV plaque reduction by *R. palmatum* extracts, chrysophanol and aloe-emodin {#Sec13}
----------------------------------------------------------------------------

To test antiviral effects of *R. palmatum* against JEV, both extracts were tested by plaque reduction assay in BHK-21 cells (Fig. [2](#Fig2){ref-type="fig"}; Table [1](#Tab1){ref-type="table"}). *R. palmatum* methanol extract manifested potent anti-JEV activity (IC~50~ = 15.04 μg/ml). Also, water extract containing a low amount of chrysophanol or aloe-emodin had low anti-JEV activity (IC~50~ = 51.41 μg/ml). Still, both extracts showed therapeutic index (CC~50~/IC~50~) \> 10. Chrysophanol and aloe-emodin also had concentration-dependently inhibitory effects on JEV plaque reduction; IC~50~ values were 15.82 and 17.39 μg/ml, respectively. Therapeutic index of chrysophanol was higher than aloe-emodin.Fig. 2Plaque reduction of JEV by *R. palmatum* extracts (**a**) and major components (**b**). Methanol and water extracts of *R. palmatum* and its components chrysophanol and aloe-emodin were serial diluted and mixed with JEV (100 pfu), and then each mixture was immediately added into the well of BHK-21 cell monolayer at 37 °C for 1 h and then overlaid with MEM medium containing 1.1 % methylcellulose. Viral plaques were stained with naphthol blue-black dye after 3 days of incubation

Virucidal activity of *R. palmatum* extracts, chrysophanol and aloe-emodin {#Sec14}
--------------------------------------------------------------------------

To ascertain whether virucidal effect correlates with *R. palmatum* activity against JEV, *R. palmatum* extracts, chrysophanol and aloe-emodin were mixed along with JEV, incubated at 4 °C for 1 h and residual infectivity was examined by plaque assay (Fig. [3](#Fig3){ref-type="fig"}; Table [1](#Tab1){ref-type="table"}). Results indicate both extracts, chrysophanol and aloe-emodin, exhibiting concentration-dependent virucidal activity as well as significant inhibitory effects on residual infectivity compared to controls. Virucidal IC~50~ values on JEV infectivity were 7.58 μg/ml of methanol extract, 17.36 μg/ml of water extract, 0.75 μg/ml of chrysophanol, and 0.46 μg/ml of aloe-emodin, respectively.Fig. 3Virucidal activities of *R. palmatum* extracts (**a**) and major components (**b**). JEV (10^5^ pfu) was mixed with indicated concentrations of extracts, chrysophanol, or aloe-emodin for a 60-min incubation at room temperature. Serial dilution of each extract/virus or compound/virus mixture was added onto BHK-21 cell monolayer in 6-well plates for plaque assays. The residual infectivity was performed as described in the plaque assay

Inhibition of JEV yields by chrysophanol and aloe-emodin {#Sec15}
--------------------------------------------------------

To detect *R. palmatum* inhibition of virus yields in vitro, viral loads in cultured supernatants for JEV-infected cells with or without treatment were plotted three days post infection by quantitative real-time RT-PCR (Table [2](#Tab2){ref-type="table"}). Real-time RT-PCR assay indicated RNA levels of JEV in supernatant of infected cells treated with 10 μg/ml of *R. palmatum* extracts, chrysophanol and aloe-emodin as significantly lower than those of untreated infected cells. Subtracting value of average threshold RT-PCR cycle for viral load in cultured supernatants of infected cells treated with *R. palmatum* extracts, chrysophanol and aloe-emodin from that in untreated infected cells rose above 3.3, indicating 10 μg/ml of extracts, chrysophanol or aloe-emodin had more than 1-log reduction (equal to 90 % effective concentration \[EC~90~\]) in virus RNA loads. Results indicated both extracts, chrysophanol and aloe-emodin, inhibiting JEV yields in vitro.Table 2JEV yield reduction by *R. palmatum* extracts and major componentsTreatmentCtΔCt^a^Medium25.53Methanol extract (10 μg/ml)29.944.41Water extract (10 μg/ml)32.006.47Chrysophanol (10 μg/ml)29.263.73Aloe-emodin (10 μg/ml)32.256.72^a^ΔCt:Ct experimental − Ct control

Activation of GAS-driven promoter activity by chrysophanol and aloe-emodin {#Sec16}
--------------------------------------------------------------------------

To examine other possible antiviral mechanism like induction of IFN response, in vivo signalling pathways in BHK-21 cells treated with *R. palmatum* extracts, chrysophanol and aloe-emodin were further detected by dual-luciferase reporter assay (Fig. [4](#Fig4){ref-type="fig"}). Cells were co-transfected with a pGAS-Luc plasmid containing GAS-driven cis-reporter (firefly luciferase) and internal control reporter (Renilla luciferase). After treatment for 4 h, relative expression of firefly luciferase driven from the indicated GAS-driven firefly luciferase activity was normalized by Renilla luciferase. Ratio of firefly luciferase intensity revealed that both extracts of *R. palmatum*, chrysophanol and aloe-emodin significantly increased activity of GAS-driven promoter. Aloe-emodin showed the highest ability to activate the GAS-driven promoter among them.Fig. 4Effects of *R. palmatum* extracts, chrysophanol and aloe-emodin on the in vivo GAS-driven signaling pathway

Discussion {#Sec17}
==========

The *R. palmatum* methanol extract showed more potent anti-JEV activity with IC~50~ less than 20 μg/ml (Fig. [1](#Fig1){ref-type="fig"}a; Table [1](#Tab1){ref-type="table"}) than water extract, being associated higher level of chrysophanol and aloe-emodin in methanol extract (Figs. [1](#Fig1){ref-type="fig"}--[2](#Fig2){ref-type="fig"}; Table [1](#Tab1){ref-type="table"}). Related components chrysophanol (IC~50~ = 15.82 μg/ml) and aloe-emodin (IC~50~ = 17.39 μg/ml) significantly inhibited JEV replication in vitro, implying anti-JEV activity being associated with amount of chrysophanol and aloe-emodin in the extract. Results concurred with our prior studies, in that aloe-emodin definitely inhibited JEV and EV71 yields in human HL-CZ promonocyte cells and TE-671 medulloblastoma cells (Lin et al. [@CR16]). Aloe-emodin also exhibits multiple antiviral effects: e.g., herpes simplex Types 1 and 2, varicella-zoster, pseudorabies and influenza (Sydiskis et al. [@CR25]). Similar effect of chrysophanol derivatives has been reported in HBV, HCV, poliovirus Types 2 and 3 (Li et al. [@CR14]; Semple et al. [@CR23]; Wohlfarth and Efferth [@CR28]). To our knowledge, this study was first to report the antiviral activity of *R. palmatum* methanol extract and chrysophanol against JEV.

*Rheum palmatum* extracts exhibited virucidal IC~50~ value below 20 μg/mL, indicating their direct action against JEV (Fig. [3](#Fig3){ref-type="fig"}; Table [1](#Tab1){ref-type="table"}). Chrysophanol and aloe-emodin also had potent virucidal activity, with virucidal IC~50~ value less than 1 μg/mL, linked with virucidal activity of *R. palmatum* extracts against JEV. The result was similar to the prior study, in that aloe emodin exhibited the virucidal activity against herpes simplex Types 1 and 2, varicella-zoster, pseudorabies, influenza, but not adenovirus, and rhinovirus (Sydiskis et al. [@CR25]). Moreover, the other anthraquinone derivative hypericin indicated their antiviral and virucidal activities against vesicular stomatitis, herpes simplex types 1 and 2, parainfluenza, and vaccinia viruses (Andersen et al. [@CR1]). Thus, we first demonstrated *R. palmatum* extracts, chrysophanol and aloe-emodin exhibiting virucidal activity against JEV. Electron microscopic examination revealed anthraquinones partially disrupting the envelopes of herpes simplex viruses, suggesting the action as one of virucidal mechanisms by anthraquinones (Sydiskis et al. [@CR25]). Since anthraquinones has been reported to inactivate non-enveloped viruses including enterovirus 71, poliovirus Types 2 and 3 (Lin et al. [@CR16]; Semple et al. [@CR23]), broad-spectrum antiviral and virucidal activities of *R. palmatum* extracts, chrysophanol and aloe-emodin against JEV and other viruses are still required to deeply elucidate mechanisms.

JEV yield assays indicated that *R. palmatum* extracts, chrysophanol and aloe-emodin had a more significant reduction (Table [2](#Tab2){ref-type="table"}). Our results indicated that anti-JEV action of aloe-emodin showed higher inhibitory effect on JEV yields than chrysophanol as well as water extract higher than methanol extract. Except virucidal activity, the result implied that water extract and aloe-emodin could exhibit different anti-JEV actions. *R. palmatum* water extract has been demonstrated antiviral activities against herpes simplex virus type 1, poliovirus type 1, measles virus and SARS coronavirus (Kurokawa et al. [@CR12]; Xu et al. [@CR27]). Interestingly, *R. palmatum* extract had anti-SARS-3CL protease activity (Luo et al. [@CR17]). *R. palmatum* water extract could contain some potent components directly acting against JEV. We previously showed aloe-emodin significantly activated ISRE and GAS-driven cis-reporting systems and induced NO production in human monocytes and medulloblastoma cells (Lin et al. [@CR16]). This study indicated induction activity of GAS-driven promoter was aloe-emodin \> chrysophanol \> methanol extract \> water extract (Fig. [4](#Fig4){ref-type="fig"}). The GAS element exists in the genes deriving a variety of antiviral actions, such as responses to IFN α/β, antigen processing and presentation, immune effector action and apoptosis (Cheney et al. [@CR3]; Larkin et al. [@CR13]; Moraes et al. [@CR19]; Mossel et al. [@CR20]; Peng et al. [@CR21]; Scagnolari et al. [@CR22]). Therefore, chrysophanol and aloe-emodin could activate GAS-driven genes as the indrect actions of IFN-γ triggering host innate immune responses against JEV infection.

*Rheum palmatum* methanol extract containing high amount of chrysophanol and aloe-emodin significantly showed dose-dependent antiviral activities against JEV. Chrysophanol with a higher therapeutic index than aloe-emodin exhibited potent virucidal activity at concentrations of less than 1 μg/ml, reducing 90 % virus yields in vitro at a concentration of 10 μg/ml, and inducing GAS-driven promoter activation as type II IFN-inducers. *R. palmatum* methanol extract and chrysophanol could exhibit multiple antiviral action against JEV infection, being promising for development of potential antiviral drugs.
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